StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Vertex (VRTX) PT Lowered to $-- at Stifel
May 7, 2024 6:13 AM
Stifel analyst Paul Matteis lowered the price target on Vertex (NASDAQ: VRTX) to $-- (from $430.00) while maintaining a Hold ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst PT Change
Next Articles
Vertex (VRTX) PT Raised to $424 at RBC Capital
May 7, 2024 6:21 AM
Vertex (VRTX) PT Lowered to $402 at Morgan Stanley
May 6, 2024 11:42 PM
Vertex Pharma (VRTX) Tops Q1 EPS by 68c; reiterates guidance
May 6, 2024 4:06 PM
Form 8-K VERTEX PHARMACEUTICALS For: May 06
May 6, 2024 4:03 PM
Vertex Reports First Quarter 2024 Financial Results
May 6, 2024 4:01 PM
Form 4 VERTEX PHARMACEUTICALS For: May 01 Filed by: Upadhyay Suketu
May 3, 2024 4:26 PM
Form 4 VERTEX PHARMACEUTICALS For: May 01 Filed by: Thornberry Nancy
May 3, 2024 4:24 PM
Form 4 VERTEX PHARMACEUTICALS For: May 01 Filed by: SACHS BRUCE I
May 3, 2024 4:22 PM
Form 4 VERTEX PHARMACEUTICALS For: May 01 Filed by: MCKENZIE DIANA
May 3, 2024 4:19 PM
Form 4 VERTEX PHARMACEUTICALS For: May 01 Filed by: Lagarde Michel
May 3, 2024 4:17 PM
Form 4 VERTEX PHARMACEUTICALS For: May 01 Filed by: Kearney Terrence C
May 3, 2024 4:15 PM
Form 4 VERTEX PHARMACEUTICALS For: May 01 Filed by: Garber Alan M
May 3, 2024 4:12 PM
Form 4 VERTEX PHARMACEUTICALS For: May 01 Filed by: CARNEY LLOYD
May 3, 2024 4:10 PM
Form 4 VERTEX PHARMACEUTICALS For: May 01 Filed by: Bhatia Sangeeta N.
May 3, 2024 4:06 PM
